TI
DTIL icon

Trexquant Investment’s Precision BioSciences DTIL Stock Holding History

Trexquant Investment’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Sell
26,066
-14,190
-35% -$65.5K ﹤0.01% 1689
2025
Q4 		$167K Buy
+40,256
New +$229K ﹤0.01% 1531
2021
Q3 		– Sell
-815
Closed -$306K – 1218
2021
Q2 		$306K Buy
+815
New +$245K 0.03% 698
2020
Q3 		– Sell
-703
Closed -$176K – 1267
2020
Q2 		$176K Buy
703
+55
+8% +$12K 0.01% 1066
2020
Q1 		$117K Buy
+648
New +$170K 0.01% 1036

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Trexquant Investment's DTIL Position: Q1 2026 in Review

Trexquant Investment reduced its Precision BioSciences (DTIL) stake by 35% in Q1 2026, selling an estimated $65.5K and leaving 26,066 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Trexquant Investment first reported a position in DTIL in Q1 2020 and has held it in 5 quarters since. The position peaked at $306K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Trexquant Investment held 26,066 shares of Precision BioSciences worth $143K as of Q1 2026.
  • Trexquant Investment sold 14,190 Precision BioSciences shares in Q1 2026, an estimated $65.5K.
  • Precision BioSciences made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1689 holding.
  • Trexquant Investment first reported a position in Precision BioSciences in Q1 2020 and has held it in 5 quarters since.
  • Trexquant Investment's Precision BioSciences position peaked at $306K in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.